Once-Daily PREZISTA (darunavir) For Treatment-Nave Adults with Hiv-1 Receives Approval in the European Union as Part of Combination Therapy

Links shared publicly online about this topic.

  • 2,282
    total visits

Once-Daily PREZISTA (darunavir) For Treatment-Nave Adults with Hiv-1 Receives Approval in the European Union as Part of Combination Therapy

jnj.com

Johnson & Johnson news and information regarding our operations, products, leaders, and our charitable giving.

View full resource at jnj.com

Tags: HIV Medication, Prezista, Johnson & Johnson, Surgery, News

  • Share

Most Recently Shared on February 4, 2009 at 11:40 am By:

eyeonfda eyeonfda

1xDaily PREZISTA® (darunavir) For Treatment-Naïve Adults w/Hiv-1 Gets Approval in the EU as Part of Combo Therapy - http://bit.ly/4DCkTr

3 years ago...

Advertisement